ABSTRACT
INTRODUCTION
The suppression subtractive hybridization (SSH) technique has been previously used to identify transcripts that are differentially expressed in a tissue/cell line of interest (2, 3) . The subtracted tissue-specific cDNA pool consists most, if not all, of the differentially expressed genes that have been normalized in their abundance. Hence, it can be used effectively as a hybridization probe in library screening. In our previous study (2) , we identified chromosome-specific sequences by using the subtracted testis-specific cDNA mixture to screen a human Y chromosome cosmid library.
In this article, we describe a new application of the SSH technique to rapidly identify the genes that are preferentially expressed in both testis and ovary. Our experimental scheme involves parallel screening of a subtracted testis cDNA library with both testis-and ovary-specific cDNA probes. This newly developed method can in principle also be applied to more than two tissues to identify genes only present in certain tissues or cells as well as to find genes up-or down-regulated as a result of differences in developmental stage or external stimuli.
MATERIALS AND METHODS
Subtracted cDNA libraries for testis and ovary were constructed as described (2) using the PCR-Select ™ cDNA Subtraction Kit (CLONTECH Laboratories, Palo Alto, CA, USA). For inquiries regarding the adaptor sequences and protocols, one of the authors (C.C. Huang) can be contacted at cchuang@clontech.com.
Tester (the population containing tissue-specific sequences) and driver (the reference population) cDNAs from respective tissues were digested by the restriction enzyme Rsa I. Two different adaptors were then ligated to pools of the tester cDNA in separate tubes. Next, 20 ng of the ligated tester and 600 ng of non-ligated driver cDNAs were mixed, denatured and allowed to re-anneal. After subtractive hybridization, 1 µ L of cDNA was amplified by two rounds of polymerase chain reaction (PCR). Either testis or ovary cDNA was used as a tester, and the mixture of cDNA synthesized from nine other human tissues (thymus, brain, liver, placenta, spleen, lung, kidney, heart and skeletal muscle) was used as the driver. Equal amounts of mRNA from each driver tissue were pooled before cDNA synthesis. As a negative control, a reverse subtraction was also performed: testis and ovary cDNA were used as the driver, and the mixture of the other nine cDNAs was used as the tester.
Subtracted testis cDNAs were inserted into the pCR ® II vector using a TA Cloning ® Kit (Invitrogen, Carlsbad, CA, USA). For differential screening of the subtracted testis library, the cDNA inserts were amplified from individual colonies of the library and blotted onto a Nytran ® nylon membrane (Schleicher & Schuell, Keene, NH, USA). This method of filter preparation was chosen over the colony-lift procedure because of its higher screening sensitivity and lower background. Individual colonies were grown in 100 µ L of LB medium containing 100 µ g/mL ampicillin in a 96-well plate for 2 h at 37°C. One microliter of the culture was transferred to a 96-well PCR plate, which contained 19 µ L of master mixture assembled from the components of the Advantage ™ KlenTaq Polymerase Mix (CLONTECH) and 4 pmol of nested primers 1 and 2 (PN1: 5 ′ -TCGAGCG-GCCGCCCGGGCAGGT and PN2: 5 ′ -AGGGCGTGGTGCGGAGGGCGGT) as described (2) . The PCR was performed with the following parameters: 95°C for 5 min; 25 cycles at 94°C for 30 s and 68°C for 3 min (GeneAmp ® PCR System 9600; Perkin-Elmer, Norwalk, CT, USA). The average insert size is about 300-400 bp, and more than 90% of randomly selected clones contained inserts. To prepare for blotting, 20 µ L of PCR product were mixed with 10 µ L of 0.3 N NaOH/15% Ficoll ® /0.5% bromophenol blue. Next, 2 µ L of each denatured DNA sample were transferred to a nylon membrane using a Hydra ™-96 Automatic Dispenser (Robbins Scientific, Sunnyvale, CA, USA) in a 96-well format. Most of the cDNA clones were similar in length, and an approximately equal amount of DNA from each clone was loaded on the filters. Three identical blots were produced for each set of cDNA samples; the membranes were UV cross-linked (Stratagene, La Jolla, CA, USA) and neutralized in 0.1 M Tris (pH 7.4), 2 × standard saline citrate (SSC) before hybridization.
The cDNA hybridization probes were prepared from the three subtracted cDNAs: subtracted testis, subtracted ovary and reverse-subtracted cDNAs. Each cDNA molecule carries adaptor 1 and adaptor 2 sequences on its ends; these adaptor sequences must be removed from the subtracted cDNA probe to prevent cross-hybridization. The adaptor sequences were designed to recreate Rsa I restriction sites after their ligation to the Rsa I-digested tester cDNAs. The adaptor 1 sequence also contains the Sma I ( Sr f I, Xma I) restriction recognition site. Thus, to prepare the subtracted cDNA probe, about 2 µ g of each subtracted PCR cDNAs were purified and digested with Rsa I and Sma I restriction enzymes. The samples were electrophoresed on a 2% agarose gel until the adaptors were well separated from the cDNAs. The gel piece containing the adaptors (22 bp) was removed and discarded. To increase the yield of the cDNA recovery, the gel was then run backwards until the samples were close to the wells; this ensured that the DNAs were concentrated in a small area. The cDNAs were then recovered using a QIAquick ™Gel Extraction Kit (Qiagen, Chatsworth, CA, USA) and were radiolabeled with 32 P[dCTP] by random priming (Ambion, Austin, TX, USA). Equal counts (5-7 × 10 7 counts per minute [cpm]) of the probes from subtracted testis, ovary and driver cDNAs were heat-denatured and used to probe the DNA dot blots in ExpressHyb ™ Hybridization Solution (CLONTECH).
RESULTS AND DISCUSSION
One representative result from the differential screening experiments is shown in Figure 1 . Most of the putative testis-specific cDNAs on the dot blot hybridized to the testis-specific probe (Figure 1 and unpublished results) . The hybridization efficiency of each individual clone is found to be varied, which is possibly due to the difference in probe length and in its hybridization characteristics ( Figure 1, Panel A) . The variation may also be due to a possibility that we have only achieved partial normalization during subtraction. Some of the putative testis-specific cDNAs also hybridized to the ovaryspecific probe (Figure 1, Panel B) , suggesting the potential simultaneous expression of those cDNAs in testis and ovary. Clones that hybridized to the reverse-subtracted cDNAs (Figure 1 , Panel C) represented the background clones that were not specific to testis. During subtraction, some residual cDNA sequences common to tester and driver might not be completely subtracted, but can be identified using the reverse-subtracted cDNA probe. Thus, from 96 putative testis-specific clones shown in Figure 1 , three clones were identified as differentially expressed in both testis and ovary.
By screening about 2000 testis-specific colonies in this manner, we were able to identify a total of 14 clones that hybridized to both testis-and ovaryspecific subtracted probes. The inserts of these 14 clones were amplified by PCR using PN1 and PN2 primers and radiolabeled with 32 sponded to several mRNA transcripts that are only expressed in testis and ovary. Clone TX22A10 (Figure 2 , Panel B) corresponded to an mRNA transcript that is highly expressed in testis and ovary but has much lower expression level in other tissues. Clones T16E12 ( Figure 2 , Panel E) and TX23C12 ( Figure 2 , Panel C) hybridized to an mRNA transcript only present in testis and ovary (e.g., as indicated by an arrow in Panel C) and to some common mRNA transcripts of different sizes, some of which might be caused by cross hybridization. These 12 clones were sequenced and analyzed for homology in the GenBank ® databases using the basic local alignment search tool (BLAST) program ( http://www.ncbi.nlm.nih.gov/ BLAST/ ). They were found to be derived from 5 unique genes (Table 1) . Seven of the 12 identified clones included three different fragments of the gene encoding human steroidogenic acute regulatory protein (StAR), which was previously found only in tissues that carry out mitochondrial sterol oxidation (e.g., testis, ovary and a small amount in kidney tissue) (Reference 5; see Figure 2A ). Two clones corresponded to cDNAs encoding human poly(ADP-ribose) polymerase (6) . The mRNA transcript of 3.8-kb poly(ADPribose) polymerase ( Figure 2E ) is expressed more in both testis and ovary than in the other six tissues, but the clone T16E12 also hybridized to a 1.4-kb mRNA. Clone TX22A10 was found to contain certain homology with mouse transporter protein (4) and a human cDNA clone ORF13. For the rest of the two cDNA sequences, we did not find significant matches with entries in the databases.
The SSH technique has been useful for generating tissue-specific cDNA libraries (2). The present study demonstrates that differentially expressed genes in multiple tissues can be identified by screening a subtracted cDNA library using the respective tissue-specific cDNA mixtures as probes. With automation, this screening procedure can be used to examine and analyze a larger number of samples. The falsepositive clones could be easily eliminated by using a reverse-subtracted probe so that genes that are differentially expressed in two or more tissues can be rapidly identified (1). The newly developed strategy described here will be very useful for identifying a set of genes up-or down-regulated in multiple tissues/cell lines as a result of differences in developmental stage, cell type or external stimuli.
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